1. Articles in category: Other Business News

    961-984 of 1221 « 1 2 ... 38 39 40 41 42 43 44 ... 49 50 51 »
    1. Signatec Data Acquisition and Playback Systems Sustain 2.8 GB/s With No Data Loss

      Signatec Data Acquisition and Playback Systems Sustain 2.8 GB/s With No Data Loss
      Signatec Inc. today released its DR2800 signal recording system platform capable of sustaining 2.8 GB/s of data recording directly to a high-speed RAID system. Ideally suited for the Synthetic Aperture Radar (SAR), Wideband Flight Recorder and advanced Optical Coherence Tomography (OCT) industries, the DR2800 platform’s industry-leading data recording rate is achieve by combining two or more of Signatec’s PCI Express (PCIe)-based high speed analog signal digitizers to continuously record 2800 MB/s of 8-bit or 14-bit data for the entire 6 to 96 TB RAID volume with no breaks in the signal record.
      Read Full Article
      Mentions: Signatec
    2. Volcano revenue rises, but bottom line shrinks

      San Diego-based medical equipment maker Volcano Corp., which operates a manufacturing facility in Rancho Cordova, saw sizable revenue gains in 2009 but posted losses for the final quarter and year. The company reported revenue of $71 million for the quarter ended Dec. 31, up 44 percent from $49.3 million in the year-ago period. The company said revenue was boosted by $5.8 million from Axsun Technologies Inc., which Volcano acquired in the fourth quarter of 2008. Still, Volcano lost $12.1 million, or 25 cents a share, in the final quarter, compared with earnings of $1.4 million, or ...
      Read Full Article
    3. Functional Measurement Functioning Well at Volcano

      Functional Measurement Functioning Well at Volcano
      To stent or not to stent? The question is more than a rhetorical one when a patient is on the cath lab table and a coronary blockage is seen on the angiogram. Luckily, there are methods available to help give a more scientific answer to this question. Equipment for two of these techniques, Intravascular Ultrasound (IVUS) and Fractional Flow Reserve (FFR -- a.k.a. "functional measurement") is manufactured by Volcano Corporation (Nasdaq: VOLC) a San Diego-based device company that announced its fourth quarter results earlier today.
      Read Full Article
    4. Volcano Slips To Loss In Q4; Provides FY10 Outlook

      Volcano Slips To Loss In Q4; Provides FY10 Outlook
      Volcano Corporation (VOLC: News ) reported a fourth-quarter net loss of $12.07 million or $0.25 per share compared to profit of $1.36 million or $0.03 per share last year. Non-GAAP net income increased to $6.96 million or $0.14 per share from $4.17 million or $0.08 per share last year. On average, 10 analysts polled by Thomson Reuters expected the company to report a loss of $0.02 per share for the quarter. Analysts' estimates typically exclude special items. Revenues increased to $71.01 million from $49.25 million a year ago. Analysts expected ...
      Read Full Article
    5. Volcano Reports 44 Percent Increase in Fourth Quarter Revenues

      Volcano Reports 44 Percent Increase in Fourth Quarter Revenues
      SAN DIEGO, March 3 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that revenues for the quarter ended December 31, 2009, were $71.0 million, an increase of 44 percent versus revenues of $49.3 million in the fourth quarter a year ago. Revenues for the fourth quarter of 2009 included $5.8 million from Axsun Technologies, Inc., which Volcano acquired in the fourth quarter of 2008, and contributed $578,000 in revenues in the fourth quarter ...
      Read Full Article
    6. Cement not included – 10:1 return on investment from federal infrastructure investment in photonics

      Cement not included – 10:1 return on investment from federal infrastructure investment in photonics
      Responding to the credit crisis and resulting global recession, national governments around the world are furiously pumping cement-truck loads of money into infrastructure projects. Some of these economic stimulus initiatives will work, some will fail, and few will offer a specific Return On Investment (ROI). Roads, bridges buildings and last generation manufacturing jobs are important – and easy to justify in a political context. Yet building a next generation of successful “cement not included” innovation companies will in turn generate long-term jobs, exports, tax bases, and ultimately pay the tab on the short-term stimulus spends.
      Read Full Article
    7. Michelson Diagnostics Reports First Quantitative Results on Cancer Diagnosis Using Multi-beam OCT imaging

      Michelson Diagnostics Reports First Quantitative Results on Cancer Diagnosis Using Multi-beam OCT imaging
      The first quantitative results from a study on the use of multi-beam OCT imaging for oral cancer diagnosis have been announced at the 2nd Scientific Meeting of the Head and Neck Optical Diagnostics Society (HNODS), held in San Francisco, 23-24 January, as part of SPIE Photonics West. The presenting authors, Professor Colin Hopper, Dr Waseem Jerjes, and Zaid Hamdoon of University College Hospital London, concluded from the study that multi-beam OCT imaging will be a very useful clinical diagnostic tool for early diagnosis of oral cancer, and for measurement of tumour resection margins in oral cancer. In the study, the ...
      Read Full Article
    8. Supporting New Ideas, New Discoveries And Jobs In Waterloo Region McGuinty Government Boosts World-Leading Research

      Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye Developing instruments to combat an epidemic of vision loss Lead researcher: Dr. Christopher Hudson Provincial funding: $2,478,074 Number of researchers affected: 9 Key private sector partners: Photon etc. Inc., Optovue Inc.
      Read Full Article
    9. Volcano Reports Revenues Of $53.9 Million In Q3 2009

      Volcano Reports Revenues Of $53.9 Million In Q3 2009
      Volcano Corporation - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals. Volcano Corporation is engaged in the development, manufacture and commercialization of a wide range of functional measurement and intravascular ultrasound products. The company's products are used for treating and diagnosing structural and vascular heart diseases. The company is headquartered in California, United States
      Read Full Article
    10. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast

      SAN DIEGO, Feb. 24 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will report its operating results for the fourth quarter and all of fiscal 2009 on Wednesday, March 3. The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 2 p.m., Pacific Standard Time, (5 p.m., Eastern Standard Time), Wednesday, March 3, hosted by Scott Huennekens, president and chief executive officer ...
      Read Full Article
    11. Looking ahead to Volcano Corporation earnings

      Traders watch earnings filings with particular interest, as changes in a company’s ratios can be a good indication whether a company is on the right track, or headed the wrong way. Volcano Corporation (VOLC) is scheduled to release its earnings results Tuesday. The company currently has an earnings per share ratio (EPS trailing twelve months) of - .32 and investors are hoping to see that number change. Let’s take a look at the performance of the stock since its previous earnings release. In the past three months, the stock has posted a 33.16% gain in terms of stock ...
      Read Full Article
    12. Large Healthcare Track Featured at Roth Capital Partners 22nd Annual OC Growth Stock Conference March 15-17, 2010

      NEWPORT BEACH, Calif.----ROTH Capital Partners , www.roth.com, a full service investment bank recognized for providing financing and advisory services to emerging growth companies worldwide, today announced that the upcoming 22nd Annual OC Growth Stock Conference will include a healthcare track featuring the management teams from over 100 healthcare companies.
      Read Full Article
    13. Avinger, Inc. Announces Completion of Merger With Sawtooth Labs, Inc.

      Avinger, Inc. Announces Completion of Merger With Sawtooth Labs, Inc.
      REDWOOD CITY, Calif., Feb. 22 /PRNewswire/ -- Avinger, Inc. and Sawtooth Labs, Inc., the two latest ventures started by John B. Simpson, Ph.D., M.D., announced the successful completion of their merger to form a single organization under the Avinger name. The larger unified company is developing innovative catheter-based technologies treating vascular disease. This is the eighth company founded by Dr. Simpson, interventional cardiologist and renowned medical device entrepreneur, whose pioneering efforts have provided patients with advanced therapies in a variety of areas, including coronary and peripheral directional atherectomy, chronic total occlusions (CTOs), intravascular ultrasound (IVUS), percutaneous transluminal coronary angioplasty ...
      Read Full Article
    14. Faster and More Accurate Tests Dramatically Increase Effectiveness of Cancer Treatment

      New ways of looking for – and eliminating – cancer cells left behind after surgery to treat breast cancer could reduce the need for additional surgeries and increase a patient’s quality of life. Currently, many surgeons are simply going by what they can see during surgery, a method that leaves plenty of room for error and may encourage doctors to remove more tissue than necessary or, worse, leave some cancer behind. Dr. Nirmala Ramanujam, of the Biomedical Engineering department at Duke University, reported that as many as 40 percent of women who underwent surgery to remove a tumor still had “positive ...
      Read Full Article
    15. New Report on Imalux Corporation from PRMinds

      Imalux Corporation (Imalux) is engaged in the development, manufacture and marketing of imaging systems for the diagnostic markets. Its products are developed using its Optical Coherence Tomography (OCT) technology and are used in urology, gastroenterology, gynecology, dermatology, dentistry and ENT applications. The company is headquartered in Ohio, United States. The company’s major product Niris Imaging System is an imaging tool used in the evaluation of human tissue microstructure and provides two-dimensional, cross-sectional, real-time depth visualization of normal and abnormal tissue microstructures. Imalux Corporation - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The ...
      Read Full Article
      Mentions: Imalux
    16. Volcano Has AAA Week: Accused, Approved and Acquired

      Volcano Has AAA Week: Accused, Approved and Acquired
      Volcano Corporation (Nasdaq: VOLC) has had a pretty interesting week. Last Thursday was the low point: a 13 person jury in Massachusetts Superior Court found Volcano and its subsidiary Axsun liable for a number of contractual breaches against LightLab Imaging, Inc. These all grew out of Volcano's purchase of Axsun, a company that had exclusive contracts with LightLab, Volcano's main competitor in the Optical Coherence Tomography (OCT) field. The court has set March 22 as the start of the damages assessment phase. But today, Volcano made two more positive announcements. The FDA has approved Volcano's latest IVUS ...
      Read Full Article
    17. Date Set for LightLab Damages Trial Against Volcano and Axsun - March 22, 2010

      Date Set for LightLab Damages Trial Against Volcano and Axsun -  March 22, 2010
      Follows Jury Finding That Volcano and Axsun Technologies Misappropriated LightLab Trade Secrets and that Volcano Intentionally Interfered with LightLab's Contract with Axsun WESTFORD, Mass., Feb. 9 /PRNewswire/ -- LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc. After a four week trial that addressed only the liability claims in this litigation ...
      Read Full Article
    18. Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter

      SAN DIEGO, Feb. 9 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Eagle Eye® Platinum digital IVUS catheter in the United States. This state-of-the-art catheter offers all of the benefits of the predecessor Eagle Eye® Gold catheter, plus improved deliverability and the convenience of additional radiopaque markers. Commercial release of Eagle Eye® Platinum in the U.S. is ...
      Read Full Article
    19. Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract Thrombus Aspiration Catheter

      Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract Thrombus Aspiration Catheter
      SAN DIEGO, Feb. 9 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical. Volcano became the exclusive global distributor of the Xtract™ catheter in May 2009. This acquisition reinforces Volcano's dedication to build a strategic portfolio of diagnostic and therapeutic tools to help patients with coronary artery disease at all levels of complexity, including acute myocardial infarction (AMI) or heart attacks.
      Read Full Article
    20. Volcano found guilty over OCT breach of contract

      Volcano found guilty over OCT breach of contract
      A Massachusetts Superior Court For Suffolk County jury has ruled against Volcano and its wholly owned subsidiary, Axsun Technologies, in a breach of contract lawsuit filed by Lightlab Imaging on Jan. 7, 2009. In December 2008, Volcano acquired Billerica, Mass.-based Axsun, which had an agreement to supply tunable lasers to the Westford, Mass.-based Lightlab for use in Lightlab's optical coherence tomography (OCT) imaging products until April 2016, with exclusivity in the field of coronary artery imaging expiring in April 2014, according to Volcano. Since the acquisition, Axsun has continued to supply lasers to Lightlab. The jury found ...
      Read Full Article
    21. Volcano Corporation Announces Litigation Status

      Volcano Corporation Announces Litigation Status
      SAN DIEGO, Feb. 5 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC) today announced that the jury in the litigation filed by Lightlab Imaging, Inc. on January 7, 2009 in the Superior Court of Massachusetts, Suffolk County reached a verdict against Volcano and its wholly owned subsidiary, Axsun Technologies. In December 2008, Volcano acquired Axsun, which had an agreement to supply tunable lasers to Lightlab for use in Lightlab's OCT (Optical Coherence Technology) imaging products until April 2016, with exclusivity in the field of coronary artery imaging expiring in April 2014. Since the acquisition, Axsun has continued to supply lasers to Lightlab ...
      Read Full Article
    22. An Essential and Comprehensive Market Report on Cardiovascular Interventions in Clinical Practice

      DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/dbdd3b/cardiovascular_int) has announced the addition of John Wiley and Sons Ltd's new report "Cardiovascular Interventions in Clinical Practice" to their offering. A unique text offering a comprehensive, practically oriented view on the most important interventional strategies for the treatment of cardiovascular disease. Treatments are explained in depth and include imaging techniques and functional tests. Also provides the latest scientific data and new surgical alternatives. These are presented by leading experts in the field and is ideal for those working in the field of clinical cardiology, interventional cardiology ...
      Read Full Article
    23. Carl Zeiss Meditec and University of Miami sued Optovue over Patent Infringement

      Carl Zeiss Meditec and University of Miami sued Optovue over Patent Infringement
      Carl Zeiss Meditec AG (AFX GY): A unit of the maker of medical lasers to correct vision defects and the University of Miami sued California-based Optovue Inc. in federal court in Delaware over claims it infringed two patents for technology to map the eye.
      Read Full Article
    24. Big Ideas from Small Businesses: Vision-related research by innovative thinkers - Imaging the eyes of infants

      Big Ideas from Small Businesses: Vision-related research by innovative thinkers  - Imaging the eyes of infants
      In the early 2000s, Eric Buckland quit his job in the telecommunications industry to apply his Ph.D. in optics to life sciences. "In the community of physicians, researchers, and patients, there's a degree of passion that I hadn't seen in the telecommunications space," Buckland explains. He connected with Joseph Izatt, Ph.D., who was working at Duke University on optical coherence tomography (OCT). Similar to the way that ultrasound uses sound waves to generate images of body organs, OCT uses light waves to capture high-resolution images of living tissues. An OCT system for the eyes requires people ...
      Read Full Article
    961-984 of 1221 « 1 2 ... 38 39 40 41 42 43 44 ... 49 50 51 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. Organizations in the News

    1. (2 articles) FDA
    2. (1 articles) National Eye Institute
  4. People in the News

    1. (1 articles) Kester Nahen
    2. (1 articles) Hiram G. Bezerra
  5. OCT Companies in the News

    1. (2 articles) Abbot
    2. (1 articles) Perimeter Medical Imaging
    3. (1 articles) Wasatch Photonics
    4. (1 articles) Notal Vision
    5. (1 articles) Compact Imaging, Inc